Skip to main content

Association between the growth rate of subependymal giant cell astrocytoma and age in patients with tuberous sclerosis complex

Child's Nervous System volume 32, pages 89–95 (2016)Cite this article

Abstract

Purpose

The most common neurological complications associated with tuberous sclerosis complex (TSC) include intractable seizures that begin in infancy and subependymal giant cell astrocytoma (SEGA) complicated by hydrocephalus with increasing age. Information on SEGA growth of TSC patients is limited. This study aimed to examine the TSC-SEGA growth rates by periodic neuroimaging.

Methods

This study evaluated the TSC-SEGA growth rates by serial neuroimaging. Fifty-eight patients with TSC underwent systematic evaluation, including a review of medical history and serial brain neuroimaging.

Results

While magnetic resonance imaging was more sensitive in detecting cortical tubers than computed tomography (73.1 vs. 0 %, p < 0.001), its efficacy in identifying intracranial lesions was comparable to that of computed tomography (96.2 vs. 100 %, p = 0.658). Significant tumor growth was observed in children (p = 0.012) and adults (p = 0.028) during follow-up periods, respectively (median for children 23.5 months, interquartile range 18–40 months and median for adults 23 months, interquartile range 12–34 months). Further, the SEGA growth rate in children was significantly higher than that in adults (75.6 vs. 16.5 %, p = 0.03).

Conclusions

The results of the study show that SEGA has a significantly higher growth rate in children using serial follow-up brain imaging, suggesting the importance of performing follow-up neuroimaging at yearly intervals in childhood to identify and prevent potential comorbidities.

This is a preview of subscription content, access via your institution.

Access options

Buy single article

Instant access to the full article PDF.

43,34 €

Price includes VAT (Finland)
Tax calculation will be finalised during checkout.

Fig. 1
Fig. 2
Fig. 3

References

  1. Rieger E, Kerl H (1992) The clinical spectrum of organ manifestations of tuberous sclerosis. Hautarzt 43(5):272–277

    CAS  PubMed  Google Scholar 

  2. Tan TK, Chen FL, Sheu JN, Chen SM, Huang HH, Tsai JD (2014) Tuberous sclerosis complex associated with heterotopic ossification in a young girl. Pediatr Neonatol 55(1):65–77

    Article  PubMed  Google Scholar 

  3. Tsai JD, Wei CC, Chen SM, Lue KH, Sheu JN (2014) Association between the growth rate of renal cysts/angiomyolipomas and age in the patients with tuberous sclerosis complex. Int Urol Nephrol 46(9):1685–1690

    Article  PubMed  Google Scholar 

  4. Jay V (1999) Historical contributions to pediatric pathology: legacy of Dr. Ewing. Pediatr Dev Pathol 2(6):597–599

    Article  CAS  PubMed  Google Scholar 

  5. Staley BA, Vail EA, Thiele EA (2011) Tuberous sclerosis complex: diagnostic challenges, presenting symptoms, and commonly missed signs. Pediatrics 127(1):e117–125

    Article  PubMed Central  PubMed  Google Scholar 

  6. Franz DN, Bissler JJ, McCormack FX (2010) Tuberous sclerosis complex: neurological, renal and pulmonary manifestations. Neuropediatrics 41(5):199–208

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  7. Christophe C, Sékhara T, Rypens F, Ziereisen F, Christiaens F, Dan B (2000) MRI spectrum of cortical malformations in tuberous sclerosis complex. Brain Dev 22(8):487–493

    Article  CAS  PubMed  Google Scholar 

  8. Hallett L, Foster T, Liu Z, Blieden M, Valentim J (2011) Burden of disease and unmet needs in tuberous sclerosis complex with neurological manifestations: systematic review. Curr Med Res Opin 27(8):157–183

    Article  Google Scholar 

  9. Rosser T, Panigrahy A, McClintock W (2006) The diverse clinical manifestations of tuberous sclerosis complex: a review. Semin Pediatr Neurol 13(1):27–36

    Article  PubMed  Google Scholar 

  10. Roach ES, Sparagana SP (2004) Diagnosis of tuberous sclerosis complex. J Child Neurol 19(9):643–649

    PubMed  Google Scholar 

  11. Roach ES, Gomez MR, Northrup H (1998) Tuberous sclerosis complex consensus conference: revised clinical diagnostic criteria. J Child Neurol 13(12):624–628

    Article  CAS  PubMed  Google Scholar 

  12. Northrup H, Krueger DA, International Tuberous Sclerosis Complex Consensus Group (2013) Tuberous sclerosis complex diagnostic criteria update recommendations of the 2012 international tuberous sclerosis complex consensus conference. Pediatr Neurol 49(4):243–254

    Article  PubMed Central  PubMed  Google Scholar 

  13. Wataya-Kaneda M, Tanaka M, Hamasaki T (2013) Trends in the prevalence of tuberous sclerosis complex manifestations: an epidemiological study of 166 Japanese patients. PLoS One 8(5):e63910

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  14. Krueger DA, Northrup H (2013) Tuberous sclerosis complex surveillance and management: recommendations of the 2012 International Tuberous Sclerosis Complex Consensus Conference. Pediatr Neurol 49(4):255–265

    Article  PubMed Central  PubMed  Google Scholar 

  15. Roth J, Roach ES, Bartels U, Jóźwiak S, Koenig MK, Weiner HL et al (2013) Subependymal giant cell astrocytoma: diagnosis, screening, and treatment. Recommendations from the International Tuberous Sclerosis Complex Consensus Conference 2012. Pediatr Neurol 49(6):439–444

    Article  PubMed  Google Scholar 

  16. Jóźwiak S, Nabbout R, Curatolo P (2013) Management of subependymal giant cell astrocytoma (SEGA) associated with tuberous sclerosis complex (TSC): clinical recommendations. Eur J Paediatr Neurol 17(4):348–352

    Article  PubMed  Google Scholar 

  17. Rovira À, Ruiz-Falcó ML, García-Esparza E, López-Laso E, Macaya A, Málaga I et al (2014) Recommendations for the radiological diagnosis and follow-up of neuropathological abnormalities associated with tuberous sclerosis complex. J Neurooncol 118(2):205–223

    Article  PubMed  Google Scholar 

  18. Adriaensen ME, Schaefer-Prokop CM, Stijnen T, Duyndam DA, Zonnenberg BA, Prokop M (2009) Prevalence of subependymal giant cell tumors in patients with tuberous sclerosis and a review of the literature. Eur J Neurol 16(6):691–696

    Article  CAS  PubMed  Google Scholar 

  19. Goh S, Butler W, Thiele EA (2004) Subependymal giant cell tumors in tuberous sclerosis complex. Neurology 63(8):1457–1461

    Article  PubMed  Google Scholar 

  20. Roach ES, Williams DP, Laster DW (1987) Magnetic resonance imaging in tuberous sclerosis. Arch Neurol 44(3):301–303

    Article  CAS  PubMed  Google Scholar 

  21. Inoue Y, Nemoto Y, Murata R, Tashiro T, Shakudo M, Kohno K et al (1998) CT and MR imaging of cerebral tuberous sclerosis. Brain Dev 20(4):209–221

    Article  CAS  PubMed  Google Scholar 

  22. Yates JR, Maclean C, Higgins JN (2011) Tuberous Sclerosis 2000 Study Group. The Tuberous Sclerosis 2000 Study: presentation, initial assessments and implications for diagnosis and management. Arch Dis Child 96(11):1020–1025

    Article  PubMed  Google Scholar 

  23. Nishio S, Morioka T, Suzuki S, Kira R, Mihara F, Fukui M (2001) Subependymal giant cell astrocytoma: clinical and neuroimaging features of four cases. J Clin Neurosci 8(1):31–34

    Article  CAS  PubMed  Google Scholar 

  24. Adriaensen ME, Zonnenberg BA, de Jong PA (2014) Natural history and CT scan follow-up of subependymal giant cell tumors in tuberous sclerosis complex patients. J Clin Neurosci 21(6):939–941

    Article  PubMed  Google Scholar 

  25. Altman NR, Purser RK, Post MJ (1988) Tuberous sclerosis: characteristics at CT and MR imaging. Radiology 167(2):527–532

    Article  CAS  PubMed  Google Scholar 

  26. Kotulska K, Józwiak S (2012) Subependymal giant cell astrocytoma: role of mTOR pathway and its inhibitors. In: Hayat MA (ed) Tumors of the central nervous system, vol 5. Springer, New York, pp 45–56

    Google Scholar 

Download references

Acknowledgments

This work was supported by Chung Shan Medical University Hospital (CRDA001MIC03). Authors gratefully acknowledge the support of the Taiwan Tuberous Sclerosis Complex Association, the patients, and caregivers who participated in this survey.

Author information

Affiliations

  1. School of Medicine, Chung Shan Medical University, No. 110, Section 1, Jianguo North Road, Taichung, 402, Taiwan

    Jeng-Dau Tsai, Teng-Fu Tsao, Yu-Ping Hsiao, Min-Ling Tsai & Ji-Nan Sheu

  2. Department of Pediatrics, Chung Shan Medical University Hospital, No. 110, Section 1, Jianguo North Road, Taichung, 402, Taiwan

    Jeng-Dau Tsai & Ji-Nan Sheu

  3. Children’s Hospital, China Medical University Hospital, Taichung, Taiwan

    Chang-Ching Wei

  4. School of Medicine, China Medical University, Taichung, Taiwan

    Chang-Ching Wei

  5. Department of Medical Imaging, Chung Shan Medical University Hospital, Taichung, Taiwan

    Teng-Fu Tsao

  6. Department of Dermatology, Chung Shan Medical University Hospital, Taichung, Taiwan

    Yu-Ping Hsiao

  7. Department of Health and Nutrition Biotechnology, Asia University, Taichung, Taiwan

    Henry J. Tsai

  8. Department of Life Sciences, National Chung Hsing University, Taichung, Taiwan

    Sheng-Hui Yang

  9. Department of Pharmacy, Chung Shan Medical University Hospital, Taichung, Taiwan

    Min-Ling Tsai

Authors
  1. Jeng-Dau Tsai
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Chang-Ching Wei
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Teng-Fu Tsao
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Yu-Ping Hsiao
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Henry J. Tsai
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Sheng-Hui Yang
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Min-Ling Tsai
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Ji-Nan Sheu
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Ji-Nan Sheu.

Ethics declarations

Conflict of interest

The authors have no conflicts of interest to disclose.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Tsai, JD., Wei, CC., Tsao, TF. et al. Association between the growth rate of subependymal giant cell astrocytoma and age in patients with tuberous sclerosis complex. Childs Nerv Syst 32, 89–95 (2016). https://doi.org/10.1007/s00381-015-2947-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00381-015-2947-4

Keywords

  • Tuberous sclerosis complex
  • Subependymal giant cell astrocytoma
  • Neuroimaging
  • Magnetic resonance imaging